VAERS reports by lot

GSK Varicella/Shingles lot 9X374: VAERS reports

64 VAERS reports list lot 9X374 as a GSK Varicella/Shingles vaccine, received between 2019-06-20 and 2024-05-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
64
Reports
5%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4424%
Injection-site / Local reaction3821%
Dermatological (non-injection-site)3519%
Neurological148%
Musculoskeletal137%
Cardiac / Cardiovascular116%
Allergic / Anaphylactic116%
Gastrointestinal105%
Respiratory32%
Psychiatric / Neuropsychiatric32%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

District of Columbia11
North Carolina6
New York5
Texas5
Massachusetts4
Illinois3
Georgia3
Virginia2
Arkansas2
Maine2
Pennsylvania2
Maryland1

Reports by month received

2019-064
2019-0721
2019-0812
2019-093
2019-102
2019-112
2020-031
2021-031
2021-101
2023-128
2024-013
2024-021
2024-031
2024-054

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.